Breaking News

AGC Biologics Breaks Ground on New Facility

Multipurpose facility at the CDMO’s Copenhagen, Denmark site will include a manufacturing building, an office building and a visitors center.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), broke ground on a new facility at its Copenhagen, Denmark site. This multipurpose facility will include a manufacturing building, an office building and a visitors center. The manufacturing building will be comprised of four levels holding approximately 8,000 square meters distributed across manufacturing, quality control laboratories, technical and warehouse areas. Around 250-300 new jobs will ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters